<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01040455</url>
  </required_header>
  <id_info>
    <org_study_id>200907053M</org_study_id>
    <nct_id>NCT01040455</nct_id>
  </id_info>
  <brief_title>Lansoprazole for Subgroups of Functional Dyspepsia</brief_title>
  <official_title>Therapeutic Response to Lansoprazole Among Different Subgroups of Functional Dyspepsia: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pharmacotherapy for functional dyspepsia remains unsatisfactory. Previous randomized trials
      reported conflicting results on clinical effectiveness of proton pump inhibitor in patients
      with functional dyspepsia. This study aims to examine whether lansoprazole 15mg is more
      effective than placebo for functional dyspepsia in Taiwanese patients, and to investigate the
      association between subgroups of patients and therapeutic response.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective double-blind randomized placebo-controlled trial. A total of 450
      dyspeptic adult patients, who are diagnosed with functional dyspepsia in accordance with Rome
      III criteria, are randomly allocated in a 1:1 proportion to receive either lansoprazole 15mg
      or placebo once daily for 8 weeks. Primary outcome is complete relief of dyspeptic symptoms.
      Secondary outcomes include significant symptomatic relief, improvement of dyspepsia severity,
      and health-related quality of life. We use a multiple logistic regression analysis to
      investigate whether dyspepsia subgroups are associated with different therapeutic responses.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    failure to recruit enough patients
  </why_stopped>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complete relief of dyspeptic symptoms</measure>
    <time_frame>within one week after complete study medication</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>satisfactory therapeutic response (complete or marked relief of symptoms)</measure>
    <time_frame>within one week after complete study medication</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of dyspepsia severity as measured by total scores of Hong Kong index</measure>
    <time_frame>within one week after completing study medication</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health-related quality of life as reflected in every aspect of SF-36</measure>
    <time_frame>within one week after completing study medication</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Functional Dyspepsia</condition>
  <arm_group>
    <arm_group_label>lansoprazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lansoprazole 15mg (Takepron®, Takeda Pharmaceutical Company, Osaka, Japan) once daily for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo once daily for eight weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lansoprazole</intervention_name>
    <description>lansoprazole 15mg (Takepron®, Takeda Pharmaceutical Company, Osaka, Japan) once daily for eight weeks</description>
    <arm_group_label>lansoprazole</arm_group_label>
    <other_name>Takepron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo once daily for eight weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dyspeptic adult outpatients

          -  Characteristic dyspeptic symptoms according to Rome III criteria (bothersome
             postprandial fullness, early satiation, epigastric pain, or epigastric burning)

          -  Upper gastrointestinal endoscopy excluding structural diseases

        Exclusion Criteria:

          -  aged less than 20 years old,

          -  organic lesions such as peptic ulcer, tumor of any kind, stricture or structural
             deformity, erosive esophagitis, or vasculopathy on endoscopy

          -  typical and predominant reflux symptoms (heartburn or acid regurgitation)

          -  comorbidity with malignancy, diabetes mellitus, liver cirrhosis, renal failure, or
             porphyria

          -  history of intra-abdominal surgery

          -  concurrent use of aspirin, non-steroidal anti-inflammatory drug or proton pump
             inhibitor

          -  history of allergy or severe side effects to lansoprazole

          -  pregnant or lactating women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming-Shiang Wu, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>E-Da Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Veterans General Hospital-Taipei</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital Yun-Lin Branch</name>
      <address>
        <city>Yun-Lin</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>http://www.romecriteria.org/</url>
    <description>Rome Foundation</description>
  </link>
  <reference>
    <citation>Hsu YC, Liou JM, Liao SC, Yang TH, Wu HT, Hsu WL, Lin HJ, Wang HP, Wu MS. Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria. Am J Gastroenterol. 2009 Oct;104(10):2534-42. doi: 10.1038/ajg.2009.328. Epub 2009 Jun 16.</citation>
    <PMID>19532128</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2009</study_first_submitted>
  <study_first_submitted_qc>December 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2009</study_first_posted>
  <last_update_submitted>April 13, 2014</last_update_submitted>
  <last_update_submitted_qc>April 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>functional dyspepsia</keyword>
  <keyword>lansoprazole</keyword>
  <keyword>placebo effect</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspepsia</mesh_term>
    <mesh_term>Gastritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lansoprazole</mesh_term>
    <mesh_term>Dexlansoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

